Free Trial

Novanta (NASDAQ:NOVT) Issues Q3 2025 Earnings Guidance

Novanta logo with Computer and Technology background

Key Points

  • Novanta has provided Q3 2025 earnings guidance with earnings per share forecasted between $0.780 and $0.850, lower than the consensus estimate of $0.930.
  • The company's revenue guidance for the same period is set at $244.0 million to $247.0 million, while the consensus estimate stands at $254.6 million.
  • Shares of Novanta saw a decrease of 4.3%, trading at $118.66, after the earnings guidance update was announced.
  • Five stocks we like better than Novanta.

Novanta (NASDAQ:NOVT - Get Free Report) issued an update on its third quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.780-0.850 for the period, compared to the consensus earnings per share estimate of 0.930. The company issued revenue guidance of $244.0 million-$247.0 million, compared to the consensus revenue estimate of $254.6 million. Novanta also updated its FY 2025 guidance to 3.220-3.360 EPS.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Novanta from a "hold" rating to a "buy" rating in a research note on Sunday.

Get Our Latest Stock Analysis on NOVT

Novanta Trading Down 4.3%

Shares of NASDAQ NOVT traded down $5.35 during mid-day trading on Tuesday, hitting $118.66. The stock had a trading volume of 607,377 shares, compared to its average volume of 276,216. The firm has a market cap of $4.27 billion, a P/E ratio of 60.44 and a beta of 1.48. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.70 and a current ratio of 2.56. The business has a 50 day moving average price of $126.07 and a two-hundred day moving average price of $130.08. Novanta has a 1 year low of $98.76 and a 1 year high of $186.75.

Novanta (NASDAQ:NOVT - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The technology company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.02. The company had revenue of $241.05 million for the quarter, compared to analysts' expectations of $237.97 million. Novanta had a net margin of 7.42% and a return on equity of 15.06%. Novanta's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.73 earnings per share. On average, equities analysts anticipate that Novanta will post 3.03 EPS for the current fiscal year.

Institutional Investors Weigh In On Novanta

Several hedge funds have recently bought and sold shares of NOVT. AQR Capital Management LLC lifted its stake in Novanta by 78.9% during the 1st quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company's stock valued at $537,000 after acquiring an additional 1,866 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Novanta by 1.6% during the first quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company's stock valued at $53,582,000 after purchasing an additional 6,533 shares in the last quarter. Finally, Jane Street Group LLC lifted its stake in shares of Novanta by 1,762.5% in the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company's stock valued at $7,881,000 after purchasing an additional 58,322 shares during the last quarter. Institutional investors own 98.35% of the company's stock.

About Novanta

(Get Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines